Last reviewed · How we verify
NCT04618133
Time-restricted Eating in Morning Chronotype
NA trial testing Early time-restricted eating in Overweight and Obesity in 92 participants. Completed in 22 October 2024.
15 July 2024
Quick facts
| Lead sponsor | Tinh-Hai Collet, MD |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 4 January 2021 |
| Primary completion | 15 July 2024 |
| Estimated completion | 22 October 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Early time-restricted eating
- Late time-restricted eating
- Active control — full drug profile →
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
Sponsor
Tinh-Hai Collet, MD
Who can join
Adults 25 to 50, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Overweight and obesity are highly prevalent conditions worldwide, despite active research of new interventions over decades. Current interventions include medications or bariatric surgery, but these approaches cannot be used in all patients and require clear indications and a close multidisciplinary management. Therefore most patients and physicians rely on lifestyle interventions, focusing on a balanced diet and physical exercise. Recent studies have uncovered that energy metabolism is also regulated by circadian rhythms, which depend on spontaneous diurnal oscillations of the central clock, retinal sensing of ambient light, and daily feeding-fasting cycles. The chronotype has an influence on behavioral patterns, where some people describe that they are more alert in the morning or in the evening: The morning or evening chronotypes, respectively. However, in modern societies, many people are exposed to external cues in misalignment with their circadians clocks. The mismatch between the individual chronotype and the social/work life can lead to metabolic disorders. Time-restricted eating (TRE), i.e. energy intake limited to certain windows of time without restricting calories, is an appealing approach because it proposes to realign the circadian clocks with external cues provided by the timing of food intake, thus leading to better metabolic outcomes. The investigators speculate that the TRE intervention needs to be personalized to reach efficacy in a broader population. To tailor the TRE intervention to each individual and harmonize their eating patterns in accordance to their chronotype, the investigators plan to test early TRE vs. late TRE vs. active control in overweight and obese individuals with morning chronotype.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Time-restricted eating: Watching the clock to treat obesity.
Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, et al · · 2024 · cited 83× · PMID 38176412 · DOI 10.1016/j.cmet.2023.12.004 -
Circadian rhythms and inflammatory diseases of the liver and gut.
Ferrell JM. · · 2023 · cited 7× · PMID 39958387 · DOI 10.1016/j.livres.2023.08.004 -
Circadian rhythms and gastrointestinal hormone-related appetite regulation.
Malin SK. · · 2025 · PMID 40110812 · DOI 10.1097/med.0000000000000908
Verify or expand the search:
- PubMed search for NCT04618133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Early time-restricted eating
Trials testing the same drug.
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
- NCT05660291 — A Study of Time Restricted Eating in Obese Adults · NA · active not recruiting
- NCT05310721 — Efficacy and Feasibility of Time-restricted Eating on Cardiometabolic Health in Adults With Overweight/Obesity · NA · completed
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other Tinh-Hai Collet, MD trials
Trials by the same sponsor.
- NCT05177965 — The Metabolic and Circadian Effects of Shift Work · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04618133 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tinh-Hai Collet, MD
- Last refreshed: 16 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing